The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma

[1]  D. McMillan,et al.  Relationship Between Preoperative Comorbidity, Systemic Inflammatory Response, and Survival in Patients Undergoing Curative Resection for Colorectal Cancer , 2011, Annals of Surgical Oncology.

[2]  N. Jamieson,et al.  A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma , 2011, Annals of Surgical Oncology.

[3]  E. Tartour,et al.  Immune infiltration in human tumors: a prognostic factor that should not be ignored , 2010, Oncogene.

[4]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[5]  D. McMillan.  Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[6]  D. McMillan,et al.  Comparison of the Prognostic Value of Inflammation-Based Pathologic and Biochemical Criteria in Patients Undergoing Potentially Curative Resection for Colorectal Cancer , 2009, Annals of surgery.

[7]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[8]  D. McMillan,et al.  An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer , 2008, Proceedings of the Nutrition Society.

[9]  D. McMillan,et al.  Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer , 2007, British Journal of Cancer.

[10]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[11]  J. Neoptolemos,et al.  A new approach to managing intraductal papillary mucinous pancreatic neoplasms , 2007, Gut.

[12]  Eithne Costello,et al.  Biology and management of pancreatic cancer , 2007, Postgraduate Medical Journal.

[13]  D. V. Von Hoff,et al.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma , 2007, Molecular Cancer Therapeutics.

[14]  M. Aitchison,et al.  1120: Evaluation of an Inflammation Based Prognostic Score in Patients with Metastatic Renal Cancer , 2007 .

[15]  C. McArdle,et al.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer , 2007, International Journal of Colorectal Disease.

[16]  Michael A. Choti,et al.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience , 2006, Journal of Gastrointestinal Surgery.

[17]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[18]  K. Fearon,et al.  Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. , 2006, The American journal of clinical nutrition.

[19]  M. Tattersall,et al.  Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review , 2006, Supportive Care in Cancer.

[20]  J. Morley,et al.  Cachexia: pathophysiology and clinical relevance. , 2006, The American journal of clinical nutrition.

[21]  D. McMillan,et al.  Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer , 2006, Cancer.

[22]  J. Melkko,et al.  Inflammation and prognosis in colorectal cancer. , 2005, European journal of cancer.

[23]  N. Christakis,et al.  Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Helmut Friess,et al.  Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia , 2005, Clinical Cancer Research.

[25]  R. Carter,et al.  Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas , 2004, British Journal of Cancer.

[26]  N. Funel,et al.  Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma , 2004, Journal of Clinical Pathology.

[27]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[28]  D C McMillan,et al.  Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer , 2003, British Journal of Cancer.

[29]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[30]  R. Schreiber,et al.  Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.

[31]  I Ihse,et al.  Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial , 2001, Annals of surgery.

[32]  G. Klöppel,et al.  The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation , 2000, The Journal of pathology.

[33]  A. Vigano,et al.  Clinical survival predictors in patients with advanced cancer. , 2000, Archives of internal medicine.

[34]  H. Nielsen,et al.  Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue , 1999, The Journal of pathology.

[35]  J. Shimizu,et al.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. , 1999, Journal of immunology.

[36]  A. Marrogi,et al.  Study of tumor infiltrating lymphocytes and transforming growth factor‐β as prognostic factors in breast carcinoma , 1997, International journal of cancer.

[37]  V. Kosma,et al.  Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.

[38]  Natale Cascinelli,et al.  Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma , 1996, Cancer.

[39]  M. Willson,et al.  CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011 .

[40]  A. Gamian,et al.  Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers , 2008, Clinical chemistry and laboratory medicine.

[41]  C. Mold,et al.  C-reactive protein , 2004, Immunologic research.

[42]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[43]  P. Lipponen,et al.  Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. , 1994, European journal of cancer.